Pegfilgrastim in Patients With Alcoholic Hepatitis
Public ClinicalTrials.gov record NCT02776059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Randomized, Open-label Study to Investigate the Safety and Efficacy of Pegfilgrastim (Neulasta®) in Patients With Alcoholic Hepatitis
Study identification
- NCT ID
- NCT02776059
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Timothy Morgan, MD
- Other
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Interventions
- Standard of care Drug
- Standard of care + pegfiltrastim Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 20, 2017
- Primary completion
- Mar 30, 2020
- Completion
- Mar 30, 2021
- Last update posted
- Sep 28, 2021
2017 – 2021
United States locations
- U.S. sites
- 5
- U.S. states
- 2
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VA Loma Linda Healthcare System | Loma Linda | California | 92357 | — |
| VA Long Beach Healthcare System | Long Beach | California | 98022 | — |
| LAC-USC Medical Center | Los Angeles | California | 90089 | — |
| Harbor-UCLA Medical Center | Torrance | California | 90502 | — |
| New Mexico VA Health Care System | Albuquerque | New Mexico | 87108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02776059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2021 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02776059 live on ClinicalTrials.gov.